Koninklijke Philips EBITDA 2011-2025 | PHG
Koninklijke Philips annual and quarterly EBITDA history from 2011 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Koninklijke Philips EBITDA for the quarter ending September 30, 2025 was $0.757B, a 212.74% increase year-over-year.
- Koninklijke Philips EBITDA for the twelve months ending September 30, 2025 was $2.871B, a 1164.81% decline year-over-year.
- Koninklijke Philips 2024 annual EBITDA was $2.077B, a 66.26% increase from 2023.
- Koninklijke Philips 2023 annual EBITDA was $1.249B, a 17.16% decline from 2022.
- Koninklijke Philips 2022 annual EBITDA was $1.508B, a 32.61% decline from 2021.
|
Koninklijke Philips Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $2,077 |
| 2023 | $1,249 |
| 2022 | $1,508 |
| 2021 | $2,237 |
| 2020 | $3,662 |
| 2019 | $3,521 |
| 2018 | $3,316 |
| 2017 | $2,890 |
| 2016 | $3,517 |
| 2015 | $2,577 |
| 2014 | $2,252 |
| 2013 | $4,487 |
| 2012 | $3,186 |
| 2011 | $3,471 |
| 2010 | $4,530 |
|
Koninklijke Philips Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $757 |
| 2025-06-30 | $781 |
| 2025-03-31 | $454 |
| 2024-06-30 | $879 |
| 2023-06-30 | $242 |
| 2023-03-31 | $-626 |
| 2022-06-30 | $12 |
| 2021-06-30 | $102 |
| 2020-06-30 | $252 |
| 2019-06-30 | $392 |
| 2018-06-30 | $355 |
| 2017-06-30 | $278 |
| 2016-12-31 | $1,287 |
| 2016-09-30 | $867 |
| 2016-06-30 | $776 |
| 2016-03-31 | $587 |
| 2015-12-31 | $618 |
| 2015-09-30 | $733 |
| 2015-06-30 | $750 |
| 2015-03-31 | $476 |
| 2014-12-31 | $368 |
| 2014-09-30 | $275 |
| 2014-06-30 | $870 |
| 2014-03-31 | $739 |
| 2013-12-31 | $1,544 |
| 2013-09-30 | $1,067 |
| 2013-06-30 | $1,069 |
| 2013-03-31 | $807 |
| 2012-12-31 | $652 |
| 2012-09-30 | $1,166 |
| 2012-06-30 | $638 |
| 2012-03-31 | $1,037 |
| 2011-12-31 | $601 |
| 2011-09-30 | $623 |
| 2011-06-30 | $864 |
| 2011-03-31 | $1,267 |
| 2010-12-31 | $1,532 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $27.125B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.724B | 25.32 |
| EssilorLuxottica (ESLOY) | France | $166.677B | 0.00 |
| Boston Scientific (BSX) | United States | $148.274B | 33.91 |
| Stryker (SYK) | United States | $136.154B | 27.03 |
| Medtronic (MDT) | Ireland | $118.264B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.513B | 0.00 |
| Agilent Technologies (A) | United States | $41.601B | 26.92 |
| ResMed (RMD) | United States | $36.703B | 25.40 |
| GE HealthCare Technologies (GEHC) | United States | $33.276B | 15.92 |
| Terumo (TRUMY) | Japan | $23.970B | 28.40 |
| Insulet (PODD) | United States | $22.513B | 69.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.183B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.253B | 7.47 |
| Bio-Rad Laboratories (BIO) | United States | $8.269B | 29.64 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.472B | 10.32 |
| ICU Medical (ICUI) | United States | $3.460B | 21.97 |
| Haemonetics (HAE) | United States | $3.293B | 14.24 |
| Envista Holdings (NVST) | United States | $3.198B | 18.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.950B | 13.15 |
| Perrigo (PRGO) | Ireland | $1.987B | 4.98 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.64 |
| Curaleaf Holdings (CURLF) | Canada | $1.793B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.774B | 17.72 |
| AtriCure (ATRC) | United States | $1.593B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.449B | 63.49 |
| Tilray Brands (TLRY) | Canada | $1.392B | 0.00 |
| Neogen (NEOG) | United States | $1.391B | 26.67 |
| QuidelOrtho (QDEL) | United States | $1.382B | 8.89 |
| Kestra Medical Technologies (KMTS) | United States | $1.349B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 18.63 |
| BioLife Solutions (BLFS) | United States | $1.242B | 370.43 |
| InMode (INMD) | Israel | $0.913B | 10.32 |
| Valneva SE (VALN) | France | $0.750B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.497B | 17.10 |
| SNDL (SNDL) | Canada | $0.468B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.425B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.328B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.266B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Owens & Minor (OMI) | United States | $0.246B | 2.47 |
| Viemed Healthcare (VMD) | United States | $0.242B | 19.30 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.206B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.21 |
| FitLife Brands (FTLF) | United States | $0.172B | 21.23 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Apyx Medical (APYX) | United States | $0.146B | 0.00 |
| Biote (BTMD) | United States | $0.134B | 5.42 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Sharps Technology (STSS) | United States | $0.109B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 11.95 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.11 |
| Nephros (NEPH) | United States | $0.049B | 35.38 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |